{"id":85,"date":"2023-11-07T12:19:47","date_gmt":"2023-11-07T10:19:47","guid":{"rendered":"https:\/\/www.ipsen.com\/auz\/?page_id=85"},"modified":"2024-02-15T07:03:53","modified_gmt":"2024-02-15T05:03:53","slug":"governance","status":"publish","type":"page","link":"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/","title":{"rendered":"Governance"},"content":{"rendered":"    <section class=\"sub-page-banner bg-img-enabled  banner-no-filter\" style=\"background-image:url(https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/11\/Module-1_-banner_Generation-Ipsen_-Governance-1920x280-1.jpg)\">\n                <div class=\"container content-sec\">\n            <nav aria-label=\"breadcrumb banner-font-color-blue\">\n            <ol class=\"breadcrumb\">\n                <li class=\"breadcrumb-item\"><a href=\"https:\/\/www.ipsen.com\/aus\">Home<\/a><\/li><li class=\"breadcrumb-item active\"><a class=\"link-pointer-events-none\" href=\"#\" aria-current=\"page\">Governance<\/a><\/li><\/ol>\n            <\/nav>            <h1 class=\"visible banner-font-color-white\">Governance<\/h1>\n            <p class=\"visible banner-font-color-white\">Transforming healthcare with integrity and transparency<\/p>\n        <\/div>\n    <\/section>\n\n\n\n\t<!-- Hero Carousel Start Here-->\n\t<section class=\"hero-section banner-filter\">\n\t\t<div class=\"hero_gridwidth container\"><!-- container class shown if gridlayout choosen -->\n\t\t\t<div id=\"heroCarousel\" class=\"carousel slide herocaro hero-banner-no-bg-image\" data-bs-ride=\"carousel\" data-enableplaybtn=\"1\" data-autoplay= \"\"  data-autospeed= \"\" >\n\t\t\t\t<!-- Slider Indicator-->\n\t\t\t\t<div class=\"carousel-indicators hidden\">\n\t\t\t\t<button type=\"button\" data-bs-target=\"#heroCarousel\" data-bs-slide-to=\"0\" class=\"active\" aria-current=\"true\" aria-label=\"Slide 0\"><\/button>\t\t\t\t<\/div>\n\t\t\t\t<!-- Items -->\n\t\t\t\t<div class=\"carousel-inner\">\n\t\t\t\t\t\t\n\t\t\t\t\t\t<!-- Hero Banner with carousel HTML -->\n\t\t\t\t\t\t<div class=\"carousel-item active banner-no-filter\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"bd-placeholder-img visible\" alt=\"\" width=\"100%\" height=\"100%\" src=\"https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/11\/01_4_Hero_image_Bath_road_UK_img_03_none_R_1920x720px.jpg\" \/> \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t<div class=\"container align-left\">\n\t\t\t\t\t\t\t\t<div class=\"carousel-caption\">\n\t\t\t\t\t\t\t\t\t<h1 class=\"visible text-start heading-one banner-font-color-blue\">\n\t\t\t\t\t\t\t\t\t\tFirmly committed to our company ethical culture and social responsibility \t\t\t\t\t\t\t\t\t<\/h1>\n\t\t\t\t\t\t\t\t\t<div class=\"hidden text-start banner-font-color-blue\"><\/div>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div id=\"carouselButtons\" class=\"hidden visible\">\n\t\t\t\t\t\t<button id=\"playButton\" class=\"hidden\" aria-label=\"Next-slide\" type=\"button\"><\/button>\n\t\t\t\t\t\t<button id=\"pauseButton\" aria-label=\"Next-slide\" type=\"button\"><\/button>\n\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/section>\n\t<!-- Hero Carousel End Here-->\n  \n\n\n<!--Alert Card Layout Start Here-->\n<section class=\"alertcard-section\">\n      <div class=\"container\">\n        <!--Alert Box HTML Start Here-->\n        <div class=\"alert-box info-box\">\n                    <div class=\"info-icon\">\n              <span class=\"info-circle\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/aus\/wp-content\/themes\/ipsen-main\/dist\/images\/alert-general-icon.png\" alt=\"Alert\"\/><\/i>\n            <\/div>\n                    <div class=\"info-contents\">\n          <h4 role=\"heading\" aria-level=\"2\" class=\"info-head heading-four heading-four\">Upholding ethical standards for patients and society<\/h4>\n            <p class=\"info-sub-head-para hidden heading-para\"><\/p>\n            <div class=\"alert-content visible\"><p>At Ipsen, we pride ourselves on our commitment to integrity, transparency and upholding the highest ethical standards. A fundamental pillar of our Generation Ipsen \u2013 For Positive Change initiative, we are fostering responsible management while cultivating a strong ethical culture that permeates every level of our organization. Our dedication to governance excellence ensures we always act with the best interests of patients, partners and society at heart.<\/p>\n<p><span data-contrast=\"none\">Our approach to Governance is based on three core principles:<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"none\">Doing what is right. Not what is easy.\u202f<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"none\">Guided by our Strategy to Focus, Together for Patients &amp; Society.\u202f<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"none\">Success delivered through responsible management.\u202f<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<\/div>\n          <\/div>\n        <\/div>\n        <!--Alert Box HTML Start Here-->\n      <\/div>\n    <\/section>\n<!--Alert Card Layout End Here-->\n\n\n\t<!-- Ipsen Quotes Start -->\n\t<section class=\"quotes-section\" aria-label=\"quotes-section\">\n\t\t<div class=\"container\">\n\t\t\t\t\t\t<div class=\"quote-sec-inner\"    >\n\t\t\t\t\t<div class=\"row\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"column-1 col-xl-4 col-md-6 col-xs-12 \">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"quote-img\">\n\t\t\t\t\t\t\t\t\t\t\t<img \n\t\t\t\t\t\t\t\t\t\t\t\tsrc=\"https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/11\/Module-4-Quote_Francois-Garnier_446x360pix.png\" \n\t\t\t\t\t\t\t\t\t\t\t\talt=\" Profile \"\n\t\t\t\t\t\t\t\t\t\t\t>\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"column-2 col-xl-8 col-md-6 col-xs-12 \">\n\t\t\t\t\t\t\t\t<div class=\"quote-content\">\n\t\t\t\t\t\t\t\t\t<div class=\"quote-para \">\n\t\t\t\t\t\t\t\t\t\t<p class=\"para\">\n\t\t\t\t\t\t\t\t\t\t\t<p>Our governance approach emphasizes integrity and responsibility, prioritizing what\u2019s right over what\u2019s easy. Through our dedication to collaboration and ethical management, we consistently fulfill our promise to enhance lives with innovative healthcare solutions.<\/p>\n\t\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"quote-sign-div\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"quote-author-div\">\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"quote-dash-div\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"quote-dash\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"#!\" target=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"quote-author primary-blue\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tFran\u00e7ois Garnier\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"quote-author-role\">\n\t\t\t\t\t\t\t\t\t\t\t\t\tEVP, General Counsel and Chief Business Ethics Officer \t\t\t\t\t\t\t\t\t\t\t\t<\/p> \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/section>\n<!-- Ipsen Quotes End -->\n\n\n<!--Graphics Cards Carousel Start Here-->\n\n    <section class=\"graphic-card graphics-old-layout bg-color-disabled bg-image-disabled bg-video-disabled bg-mobile-video-img-disabled\"    data-displaycards=\"3\">\n                <div class=\"container\">\n            <div class=\"text-graph-inner\">\n                <div class=\"row\">\n                    <!--Graphic info section-->\n                    <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                        <div class=\"text-graph-heading\">\n                        <h3 class=\"charcoal-grey visible heading-three\" role=\"heading\" aria-level=\"2\">\n                                Strengthening Business Ethics at Ipsen                            <\/h3>\n                            <p class=\"text-graph-para charcoal-grey visible\">Discover our commitment to responsible business practices, as we work to cultivate an ethical culture anchored in anti-corruption measures and transparency.<\/p>\n                        <\/div>\n                    <\/div><!--Graphic info section over here -->\n\n                    <!--Graphic detail section-->\n                    <div class=\"column-2 col-xl-12 col-md-12 col-sm-12\">\n                        <!-- graphic-card carousel start here -->\n                                                    <div class=\"text-graph-carousel\">\n                                <div class=\"glider-contain multiple\">\n                                                                                    <div class=\"text-graph-content-btn\">\n                                                    <button aria-hidden=\"true\" aria-label=\"Previous\" tabindex = \"-1\" class=\"glider-graphic-card-prev\"><span><\/span><\/button>\n                                                    <button aria-hidden=\"true\" aria-label=\"Next\" tabindex = \"-1\" class=\"glider-graphic-card-next\"><span><\/span><\/button>\n                                                <\/div>\n                                    \n                                <div class=\"glider-graphic-card\" tabindex=\"-1\">\n                                                                                                                    <div class=\"text-graphic\">\n                                                                                    <div class=\"text-graph-row\">\n                                             \n                                                                                                            <!-- Graphic Card With OLD layout start here -->\n                                                                                                            <div class=\"column-1\">\n                                                                                                                                                                                                                                        <div class=\"text-graph-img visible graphic-icon-enabled \">\n                                                                                                                                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/11\/CERTIFICATION_PICTO_72x72pix.jpg\" alt=\"\" \/> \n                                                                                                                                                                                                                                                    <\/div>\n                                                                                                                                                                                                                            <\/div>\n                                                                                                            <div class=\"column-2\">\n                                                                                                                <div class=\"text-graph-content\">\n                                                                                                                                                                                                                                                <div class=\"text-graph-title\">\n                                                                                                                            <h4 role=\"heading\" aria-level=\"3\">ISO 37001 anti-corruption certification <\/h4>\n                                                                                                                            <\/div>\n                                                                                                                                                                                                                                        <div class=\"text-graph-desc\">\n                                                                                                                        <p><p>We are committed to fighting corruption and continuously enhancing our anti-corruption infrastructure. Demonstrating our dedication in this regard, we renewed our ISO 37001 certification in July 2022.<\/p>\n<\/p>\n                                                                                                                    <\/div>\n                                                                                                                <\/div>\n                                                                                                            <\/div>\n                                                                                                            <!-- Graphic Card With OLD layout end here -->\n                                                                                                                                                <\/div>\n\n                                                                                    <\/div>\n                                                                                                                                                            <div class=\"text-graphic\">\n                                                                                    <div class=\"text-graph-row\">\n                                             \n                                                                                                            <!-- Graphic Card With OLD layout start here -->\n                                                                                                            <div class=\"column-1\">\n                                                                                                                                                                                                                                        <div class=\"text-graph-img visible graphic-icon-enabled \">\n                                                                                                                                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/11\/POLICY_PICTO_72x72pix-1.jpg\" alt=\"\" \/> \n                                                                                                                                                                                                                                                    <\/div>\n                                                                                                                                                                                                                            <\/div>\n                                                                                                            <div class=\"column-2\">\n                                                                                                                <div class=\"text-graph-content\">\n                                                                                                                                                                                                                                                <div class=\"text-graph-title\">\n                                                                                                                            <h4 role=\"heading\" aria-level=\"3\">Global whistleblowing policy <\/h4>\n                                                                                                                            <\/div>\n                                                                                                                                                                                                                                        <div class=\"text-graph-desc\">\n                                                                                                                        <p><p>Implemented since 2018, our Global Whistleblowing Policy encourages employees to report potential non-compliant or unethical behaviors, fostering a speak-up culture and promoting transparency and accountability.<\/p>\n<\/p>\n                                                                                                                    <\/div>\n                                                                                                                <\/div>\n                                                                                                            <\/div>\n                                                                                                            <!-- Graphic Card With OLD layout end here -->\n                                                                                                                                                <\/div>\n\n                                                                                    <\/div>\n                                                                                                                                                            <div class=\"text-graphic\">\n                                                                                    <div class=\"text-graph-row\">\n                                             \n                                                                                                            <!-- Graphic Card With OLD layout start here -->\n                                                                                                            <div class=\"column-1\">\n                                                                                                                                                                                                                                        <div class=\"text-graph-img visible graphic-icon-enabled \">\n                                                                                                                                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/11\/PEOPLE_PICTO_72x72pix.jpg\" alt=\"\" \/> \n                                                                                                                                                                                                                                                    <\/div>\n                                                                                                                                                                                                                            <\/div>\n                                                                                                            <div class=\"column-2\">\n                                                                                                                <div class=\"text-graph-content\">\n                                                                                                                                                                                                                                                <div class=\"text-graph-title\">\n                                                                                                                            <h4 role=\"heading\" aria-level=\"3\">Employee ethical culture measurement<\/h4>\n                                                                                                                            <\/div>\n                                                                                                                                                                                                                                        <div class=\"text-graph-desc\">\n                                                                                                                        <p><p>Our workforce demonstrates strong ethical foundation. One way in which we measure the strength of our ethical culture is through annual employee surveys. In 2021, 90% of global respondents reported considering compliance or ethical factors in their decision-making.<\/p>\n<\/p>\n                                                                                                                    <\/div>\n                                                                                                                <\/div>\n                                                                                                            <\/div>\n                                                                                                            <!-- Graphic Card With OLD layout end here -->\n                                                                                                                                                <\/div>\n\n                                                                                    <\/div>\n                                                                                                                                                            <div class=\"text-graphic\">\n                                                                                    <div class=\"text-graph-row\">\n                                             \n                                                                                                            <!-- Graphic Card With OLD layout start here -->\n                                                                                                            <div class=\"column-1\">\n                                                                                                                                                                                                                                        <div class=\"text-graph-img visible graphic-icon-enabled \">\n                                                                                                                                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/11\/EXPERIENCEE_PICTO_72x72pix.jpg\" alt=\"\" \/> \n                                                                                                                                                                                                                                                    <\/div>\n                                                                                                                                                                                                                            <\/div>\n                                                                                                            <div class=\"column-2\">\n                                                                                                                <div class=\"text-graph-content\">\n                                                                                                                                                                                                                                                <div class=\"text-graph-title\">\n                                                                                                                            <h4 role=\"heading\" aria-level=\"3\">Reporting concerns<\/h4>\n                                                                                                                            <\/div>\n                                                                                                                                                                                                                                        <div class=\"text-graph-desc\">\n                                                                                                                        <p><p>At Ipsen, we work to fairly address concerns that come to us. If you have an ethics issue, concern or grievance that you would like to report, you can raise your alert through the <a href=\"https:\/\/ipsen.whispli.com\/lp\/Alerts?locale=en\">Whispli<\/a> designated <a href=\"https:\/\/ipsen.whispli.com\/lp\/Alerts\">Alert Platform<\/a>\u00a0or use the email address <a href=\"mailto:Ipsen.Ethics.Hotline@ipsen.com\">Ipsen.Ethics.Hotline@ipsen.com<\/a><\/p>\n<\/p>\n                                                                                                                    <\/div>\n                                                                                                                <\/div>\n                                                                                                            <\/div>\n                                                                                                            <!-- Graphic Card With OLD layout end here -->\n                                                                                                                                                <\/div>\n\n                                                                                    <\/div>\n                                                                                                            <\/div>\n                            <\/div>\n                                            <\/div> <!-- graphic-card carousel end here -->\n                <\/div> <!--Graphic detail section over here with 12 grid -->   \n            <\/div><!--row ended here-->\n        <\/div> <!-- graph-inner ended here -->\n        \n            <div class=\"more-result-btn\">\n                                            <\/div>\n        <\/div> <!--Container class ended here -->\n    <\/section>\n<!--Graphics Cards Carousel End Here-->\n\n\n<!-- Text & Media Block Code -->\n<section class=\"two-col-section text-media-section\">\n    <div class=\"container two-section-innner section-reverse\">\n        <div class=\"response-inner\" style=\"background-image: url('')\">\n            <div class=\"row section-reverse\">\n                <div class=\"col-xs-12 col-sm-12 col-md-6\">\n                                                    <div class=\"img-video-section\">\n                                <img decoding=\"async\" \n                                    src=\"https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/11\/MicrosoftTeams-image-5.jpg\" \n                                    alt=\"\" \n                                >\n                            <\/div>\n                                        <\/div>\n                <div class=\" col-xs-12 col-sm-12 col-md-6\">\n                    <div class=\"section-content\">\n                        <div class=\"heading-dash\">\n                                                    <\/div>\n                                                    <p class=\"section-head-two heading-para\" role=\"heading\" aria-level=\"3\">\n                                    Ipsen\u2019s Code of Conduct                                <\/p>\n                                                <p>Ipsen\u2019s Code of Conduct is a dynamic blueprint that emphasises ethical decision-making, transparency and accountability across our diverse operations. This robust framework fuels an unwavering commitment to revolutionizing patient care, cultivating an empowering corporate culture, and exceeding industry standards and regulations.<\/p>\n                            <a \n                            aria-label=\"Consult the full Code of Conduct about \"  \n                                role=\"link\" \n                                class=\"btn-link section-btn cta-visible\"\n                                href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/16134025\/Code-of-Conduct-2023.pdf\" \n                                target=\"_blank\"\n                            > \n                                Consult the full Code of Conduct \n                            <\/a>\n\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n    <section class=\"title-text \">\n        <div class=\"container\">\n            <div class=\"title-text-inner\" style=\"background-color:#EDEBE4;\">\n\n                <!-- If heading is enabled then it's visible -->\n                <div class=\"text-head-dash visible\">\n                <h3 class=\"heading-three\" role=\"heading\" aria-level=\"2\">\n                        Combating corruption with ethics and transparency                    <\/h3>\n                <\/div>\n               \n                <!-- If description is enabled then it's visible -->\n                <div class=\"text-parbase visible\">\n                    <p>At Ipsen, we proudly uphold ethical standards, integrity and transparency in all of our endeavors. Robust anti-corruption policies ensure strict adherence to all applicable national and international legislation, accurate financial recordkeeping, and stakeholder interactions based on integrity and merit.<\/p>\n                <\/div>\n\n                <!-- If button is enabled then it's visible -->\n                \n            <\/div>\n        <\/div>\n    <\/section>\n\n\n\n    <!--Accordion Cards Start Here-->\n    <section class=\"accordion bg-color-disabled\"  data-according-id=\"995539131\">\n        <div class=\"container\">\n            <div class=\"row\">\n                <!--Accordion info section-->\n                <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                    <div class=\"accordian-info\">\n                        <h3 class=\"accordian-heading hidden heading-three\" role=\"heading\" aria-level=\"2\">\n                                                    <\/h3>\n                        <p class=\"accordian-summary hidden\"><\/p>\n                    <\/div>\n                <\/div><!--Accordion info section over here -->\n\n                <div class=\"col-xl-12 col-lg-12 col-md-12 col-sm-12\">\n                    <div class=\"accordion accor-group\" id=\"accordionExample995539131\">\n                         \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"faqHeading0\">\n                                            <button class=\"accordion-button accor-faq-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqHeading9955391310\" aria-expanded=\"false\" aria-controls=\"faqHeading9955391310\">\n                                                Anti-corruption at Ipsen                                            <\/button>\n                                        <\/p>\n                                        <div id=\"faqHeading9955391310\" class=\"accordion-collapse collapse \" aria-labelledby=\"faqHeading0\" data-bs-parent=\"#accordionExample995539131\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Fight against corruption is a pledge\u00a0through our Code of Conduct, as Ipsen rejects any form of corruption that distorts fair trade, hinders economic development,\u00a0and imposes multiple costs on society at large.<\/p>\n<p>&nbsp;<\/p>\n<p>Ipsen\u2019s commitment to conducting business with high standards of ethics is reflected through the Anti-Corruption Program,\u00a0for a positive societal change under the Generation Ipsen. A dedicated cross-function operational committee works on meaningful anti-corruption initiatives and regularly reports to the Executive Leadership Team.<\/p>\n<p>&nbsp;<\/p>\n<p>Ipsen has been certified since 2021 to the ISO 37001- International Anti-Corruption Standard for anti-corruption management systems, for the benefit of Patients, Society and Employees.<\/p>\n<p>&nbsp;<\/p>\n<\/p>\n                                                    <div class=\"cta-block visible\" style=\"text-align:left;\">\n                                                                                                                        <a class=\"accr-cta-link\" href=\"https:\/\/www.ipsen.com\/auz\/wp-content\/uploads\/sites\/5\/2023\/11\/Ipsen-ISO-37001-certification.pdf\" target=\"_blank\" aria-label=\"Click for Certification\"> >\n                                                                    Click for Certification                                                                <\/a>\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"faqHeading1\">\n                                            <button class=\"accordion-button accor-faq-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqHeading9955391311\" aria-expanded=\"false\" aria-controls=\"faqHeading9955391311\">\n                                                Ipsen tax strategy and governance statement                                            <\/button>\n                                        <\/p>\n                                        <div id=\"faqHeading9955391311\" class=\"accordion-collapse collapse \" aria-labelledby=\"faqHeading1\" data-bs-parent=\"#accordionExample995539131\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen is a dynamic and growing global specialty-driven biopharmaceutical group with a focus on transformative medicines in Oncology, Rare Disease and Neuroscience.<\/p>\n<p>In line with our Company Social Responsibility, we recognize our role as a responsible taxpayer to pay our full share of taxes, including corporate income taxes, as part of our contribution to society. \u00a0Thus, Ipsen pays its fair share of taxes in all countries where it operates.<\/p>\n<p>The aim of this document is to provide transparency to ensure a proper understanding of the way Ipsen approaches tax policy matters:<\/p>\n<ul>\n<li>Our compliance<\/li>\n<li>Our tax governance and risk management<\/li>\n<li>Our attitude to tax planning<\/li>\n<li>Our tax risks<\/li>\n<li>Our engagement with Tax Authorities<\/li>\n<\/ul>\n<p><strong>Our Compliance<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>The tax affairs are managed in a manner that is consistent within Ipsen\u2019s Code for Ethical conduct, to conduct business lawfully and ethically.<\/p>\n<p>Ipsen is committed to observing all applicable laws, rules and regulations in meeting its tax compliance and reporting responsibilities in all jurisdictions where it operates, and to ensuring compliance with all relevant legal disclosure requirements.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Our tax governance and risk management<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>The fundamental objective of Ipsen\u2019s tax governance is to guarantee strict compliance and transparency with the applicable tax regulations and ensure adequate supervision of the tax policy implemented by its subsidiaries in all the territories where it operates.<\/p>\n<p>Ipsen applies diligent professional care and judgement, including ensuring that all decisions are taken at an appropriate level and are supported by consistent processes and guidelines and thorough documentation. The tax function is localized in France, UK and the US. The VP Group Tax department reports to the EVP CFO and our tax professionals are committed to the highest compliance standards in tax laws and regulations.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Our attitude to tax planning<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Ipsen\u2019s approach is to pay the correct and fair amount of tax to minimise the risk of uncertainty or disputes. Our tax positions are based on reasonable interpretation of applicable law and are aligned with the substance of the economic activity of our business locally.<\/p>\n<p>We are committed to maintain and follow a transfer pricing policy that is based on OECD Transfer Pricing Guidelines notably the arm\u2019s length standard and the goals of the OECD\/G20 Base Erosion and Profit Shifting project (\u201cBEPS\u201d).<\/p>\n<p>Ipsen has a zero-tolerance approach to tax evasion and the facilitation of tax evasion. Ipsen does not undertake aggressive tax planning or artificial tax arrangements. Where available, legitimate tax incentives (for example, R&amp;D tax credits) or exemptions are implemented in the spirit in which they are intended and aligned with our commercial business activities and reputation.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Our tax risks<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Ipsen seeks to comply fully with the tax regulations and actively manages its affairs to minimise the risk of non-compliance by ensuring that tax returns and payments are made on time with proper disclosure made to the tax authorities. We strive for full compliance and are continuously improving our processes, which are based on standardization, simplification and automation.<\/p>\n<p>Areas of uncertainty and complexity of current international tax law are managed by the Tax Department and, in addition, we regularly seek advice from independent external tax advisors to minimize our tax risk.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Our engagement with the tax authorities<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>We seek to operate an honest and transparent relationship with all the tax authorities.<\/p>\n<p>We file timely and accurate tax returns, and we respond openly and promptly to any questions that may be raised in relation to our tax returns. Like any multinational company, our tax returns are continuously under audit around the world. In the event a tax authority disagrees with our views on the appropriate tax treatment of a given item, we will work constructively to try to resolve the issue in a timely manner through appropriate methods of dispute resolution.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                                                <\/div>\n                <\/div> \n            <\/div>\n        <\/div>\n    <\/section>\n    <!--Accordion Cards End Here-->\n\n\n\n    <!--Accordion Cards Start Here-->\n    <section class=\"accordion bg-color-disabled\"  data-according-id=\"1010423117\">\n        <div class=\"container\">\n            <div class=\"row\">\n                <!--Accordion info section-->\n                <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                    <div class=\"accordian-info\">\n                        <h3 class=\"accordian-heading visible heading-three\" role=\"heading\" aria-level=\"2\">\n                            Advancing ethical standards with governance actions                        <\/h3>\n                        <p class=\"accordian-summary hidden\"><\/p>\n                    <\/div>\n                <\/div><!--Accordion info section over here -->\n\n                <div class=\"col-xl-12 col-lg-12 col-md-12 col-sm-12\">\n                    <div class=\"accordion accor-group\" id=\"accordionExample1010423117\">\n                         \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"expHeading0\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading10104231170\" aria-expanded=\"false\" aria-controls=\"expHeading10104231170\">\n                                                Business ethics                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading10104231170\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading0\" data-bs-parent=\"#accordionExample1010423117\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen continuously enhances its Business Ethics Program, backed by a robust infrastructure and governance system. By fostering a culture of ownership, accountability and mindful decision-making, we maintain a strong ethical foundation, as evidenced by positive employee survey results.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"expHeading1\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading10104231171\" aria-expanded=\"false\" aria-controls=\"expHeading10104231171\">\n                                                Opportunities and Risks Governance                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading10104231171\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading1\" data-bs-parent=\"#accordionExample1010423117\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen is committed to ensuring a robust Opportunities and Risks Governance policy, with several strategic and operational committees actively working to identify, assess and address risks and opportunities.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"expHeading2\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading10104231172\" aria-expanded=\"false\" aria-controls=\"expHeading10104231172\">\n                                                Working with third parties                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading10104231172\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading2\" data-bs-parent=\"#accordionExample1010423117\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen recognizes that its third parties play an important role in Ipsen\u2019s success and commitments. \u00a0Accordingly, we strive to conduct business with organizations who share Ipsen\u2019s commitment to ethical culture and operate in a socially and environmentally responsible manner.<\/p>\n<p>&nbsp;<\/p>\n<p>The <a href=\"https:\/\/www.ipsen.com\/auz\/wp-content\/uploads\/sites\/5\/2023\/11\/Ipsen-Business-Partner-Code-of-Conduct-16th-June-2021-5.pdf\" target=\"_blank\" rel=\"noopener\"><strong><u>Ipsen Business Partner Code of Conduct<\/u><\/strong><\/a><em>\u00a0<\/em>\u00a0documents principles and expectations for establishing and maintaining a business relationship with our third parties.<\/p>\n<ul>\n<li>Ipsen complies with international and national laws, regulations and codes that prohibit any form of corruption and avoids doing business with entities and\/or individuals that are subject to official trade and economic sanctions. Following a risk-based approach, our Global Third Party Program ensures that we work with trusted and reputable third parties, that reasonably operate in a socially and environmentally responsible manner.<\/li>\n<li>Ipsen also implemented a Supplier Risk Management process using a unified digital platform and engaging cross-functional risk experts to ensure potential suppliers meet our standards. This approach streamlines assessments and strengthens risk management throughout our organization.<\/li>\n<li>Ipsen is committed to high financial compliance standards and has implemented a <em>No PO No Pay<\/em> approach for a wide majority of spend. This means third parties must have a valid purchase order before starting work and submitting an invoice for payment. Based on the country the third parties will be delivering services or goods to, the purchase order terms and conditions may slightly differ. Please click below for the applicable Purchase Order Terms &amp; Conditions<em>. <\/em><strong><a href=\"https:\/\/www.ipsen.com\/auz\/wp-content\/uploads\/sites\/5\/2023\/11\/UK-Terms-and-Conditions-of-Purchase-1.pdf\" target=\"_blank\" rel=\"noopener\">Purchase Order Terms and Conditions<\/a>\u00a0<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"expHeading3\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading10104231173\" aria-expanded=\"false\" aria-controls=\"expHeading10104231173\">\n                                                Data privacy                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading10104231173\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading3\" data-bs-parent=\"#accordionExample1010423117\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>At Ipsen, we care about protecting the personal data of all our stakeholders. We ensure that we only use personal data as necessary, that our use of that data is lawful and fair, that we keep data secure, and that we inform individuals about how we use their data. We manage privacy compliance at Ipsen through policies, procedures and training, and by fostering a strong culture of respect for privacy.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"expHeading4\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading10104231174\" aria-expanded=\"false\" aria-controls=\"expHeading10104231174\">\n                                                Working with HCPs and HCOs                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading10104231174\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading4\" data-bs-parent=\"#accordionExample1010423117\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>We are committed to fostering transparency and trust in all of our collaborations with healthcare professionals (HCPs) and healthcare organizations (HCOs). By openly disclosing information on transfers of value, clinical trials, scientific publications and interest representation activities, we ensure integrity and promote a strong ethical foundation across our interactions.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Transparency rules and reports<\/strong><\/p>\n<ul>\n<li><strong><a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12104016\/EFPIA-Code-Disclosure-2023-Self-Certificaiton.pdf\" target=\"_blank\" rel=\"noopener\">Ipsen self-certification letter<\/a><\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Please follow the links to the countries to find the information about local Transparency rules and reports:<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong><a href=\"https:\/\/d1bml1vmyeu9v2.cloudfront.net\/germany\/uber-uns\/#verpflichtungen\" target=\"_blank\" rel=\"noopener\">Austria<\/a><\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong><a href=\"https:\/\/www.betransparent.be\/en\/\" target=\"_blank\" rel=\"noopener\">Belgium<\/a><\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Bulgaria<\/strong><\/p>\n<ul>\n<li>No transfer of value in 2018, 2019, 2021, 2022<\/li>\n<li>2020 EFPIA report in euro:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102741\/Bulgaria_2020-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Bulgarian<\/strong><\/a><\/li>\n<li>Methodological note: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102743\/Bulgaria_2021-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Croatia<\/strong><\/p>\n<ul>\n<li>2017 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102748\/Croatia_2017-EFPIA-report-EURO.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2017 EFPIA report in kuna: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102750\/Croatia_2017-EFPIA-report-KUNA.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>No transfer of value in 2018, 2019, 2020, 2021, 2022<\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102752\/Croatia_2021-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Cyprus\u00a0<\/strong><\/p>\n<ul>\n<li>No Transfer of value in 2018, 2020, 2021, 2022<\/li>\n<li>2019 EFPIA report in euro:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102753\/Cyprus_2019-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.ipsen.cz\/\" target=\"_blank\" rel=\"noopener\"><strong>Czech Replublic<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsennordic.com\/commitments\/transparency-in-relations-and-interests\/\" target=\"_blank\" rel=\"noopener\"><strong>Denmark<\/strong><\/a><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Estonia<\/strong><\/p>\n<ul>\n<li>2018 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102759\/Esthonia_2018-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Estonian<\/strong><\/a><\/li>\n<li>2019 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102801\/Esthonia_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Estonian<\/strong><\/a><\/li>\n<li>2020 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102803\/Esthonia_2020-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Estonian<\/strong><\/a><\/li>\n<li>2021 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102805\/Esthonia_2021-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Estonian<\/strong><\/a><\/li>\n<li>2022 EFPIA report in euro: <strong><a href=\"https:\/\/wave-eu-west-1.s3.eu-west-1.amazonaws.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/3\/2023\/05\/31112404\/Estonia-2022_EFPIA-report_final.pdf\" target=\"_blank\" rel=\"noopener\">Estonian<\/a><\/strong><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/wave-eu-west-1.s3.eu-west-1.amazonaws.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/3\/2023\/05\/31112407\/Methodological_Note_2023_Estonia.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Estonian<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsennordic.com\/commitments\/transparency-in-relations-and-interests\/\" target=\"_blank\" rel=\"noopener\"><strong>Finland<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.transparence.sante.gouv.fr\/flow\/main;jsessionid=D2DB6E8DBDE57CE7022620DEC69729B1?execution=e1s1\" target=\"_blank\" rel=\"noopener\"><strong>France<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/ipsen-pharma.de\/verpflichtungen\/transparenz-und-vertrauen\/deutschland\/\" target=\"_blank\" rel=\"noopener\"><strong>Germany<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Greece<\/strong><\/p>\n<ul>\n<li>2018 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102812\/Greece_2018-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<li>2019 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102814\/Greece_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<li>2020 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102817\/Greece_2020-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<li>2021 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102821\/Greece_2021-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<li>2022 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/21105733\/Greece_2022-EFPIA-report.xlsx\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12105741\/Greece_2023-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Hungary<\/strong><\/p>\n<ul>\n<li>2018 EFPIA report in forint: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102830\/Hungary_2018-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2019 EFPIA report in forint: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102832\/Hungary_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2020 EFPIA report in forint: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102834\/Hungary_2020-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2021 EFPIA report in forint: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102839\/Hungary_2022-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2022 EFPIA repot in forint: <strong><a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/21105733\/Hungary_2022-EFPIA-report.xlsx\" target=\"_blank\" rel=\"noopener\">Hungarian<\/a><\/strong><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12110325\/Hungary_2022-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Iceland<\/strong><\/p>\n<ul>\n<li>No Transfer of value in 2018, 2019, 2020, 2021, 2022<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.transferofvalue.ie\/\" target=\"_blank\" rel=\"noopener\"><strong>Ireland<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/d1bml1vmyeu9v2.cloudfront.net\/italy\/chi-siamo-2\/\" target=\"_blank\" rel=\"noopener\"><strong>Italy<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.vi.gov.lv\/en\/statement-material-or-other-support-provided-associations-foundations-and-medical-treatment-institutions\" target=\"_blank\" rel=\"noopener\"><strong>Latvia<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Lithuania<\/strong><\/p>\n<ul>\n<li>2018 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102852\/Lithuania_2018-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<li>2019 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102854\/Lithuania_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<li>2020 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102855\/Lithuania_2020-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<li>2021 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102857\/Lithuania_2021-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<li>2022 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12111100\/Lithuania_2022-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12111103\/Lithuania_2022-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Luxemburg<\/strong><\/p>\n<ul>\n<li>2018 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102905\/Luxenbourg_2018-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2019 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102907\/Luxenbourg_2019-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>No Transfer of value in 2020<\/li>\n<li>2021 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102913\/Luxenbourg_2021-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2022 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12111456\/Luxenbourg_2022-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12111500\/Luxenbourg_2022-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Malta<\/strong><\/p>\n<ul>\n<li>No Transfer of value in 2018, 2019, 2020, 2021, 2022<\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102915\/Malta_2016-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsennordic.com\/commitments\/transparency-in-relations-and-interests\/\" target=\"_blank\" rel=\"noopener\"><strong>No<\/strong><strong>rway<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/d1bml1vmyeu9v2.cloudfront.net\/poland\/\" target=\"_blank\" rel=\"noopener\"><strong>Poland<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/extranet.infarmed.pt\/pmro\/Publico\/ListagemPublica.aspx\" target=\"_blank\" rel=\"noopener\"><strong>Portugal<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Romania<\/strong><\/p>\n<ul>\n<li>2018 EFPIA report:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102926\/Romania_2018-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a>\/ Rapport R&amp;D 2018:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102929\/Romania_2018-Rapport.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2019 EFPIA report:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102933\/Romania_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a>\/ Rapport R&amp;D 2019:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102934\/Romania_2019-Rapport.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2020 EFPIA report:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102938\/Romania_2020-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a>\/ Rapport R&amp;D 2020:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102940\/Romania_2020-Rapport.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2021 EFPIA report:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102944\/Romania_2021-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a>\/ Rapport R&amp;D 2021:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102947\/Romania_2021-Rapport.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2022 EFPIA report:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102950\/Romania_2022-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a>\/ Rapport R&amp;D 2022:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102952\/Romania_2022-Rapport.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li>2018 ANMDM Letter: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102917\/Romania_2018-ANMDM.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2019 ANMDM Letter: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102931\/Romania_2019-ANMDM.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2020 ANMDM Letter: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102936\/Romania_2020-ANMDM.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2021 ANMDM Letter: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102941\/Romania_2021-ANMDM.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2022 ANMDM Letter:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102948\/Romania_2022-ANMDM.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsen.com\/russia\/%d0%bf%d1%80%d0%be%d0%b7%d1%80%d0%b0%d1%87%d0%bd%d0%be%d1%81%d1%82%d1%8c-%d0%be%d1%82%d0%bd%d0%be%d1%88%d0%b5%d0%bd%d0%b8%d0%b9-%d1%81%d0%be-%d1%81%d0%bf%d0%b5%d1%86%d0%b8%d0%b0%d0%bb%d0%b8%d1%81\/\" target=\"_blank\" rel=\"noopener\"><strong>R<\/strong><strong>ussia<\/strong><\/a><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Serbia<\/strong><\/p>\n<ul>\n<li>No Transfer of value in 2018, 2019<\/li>\n<li>2020 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102954\/Serbia_2020-EFPIA-Report_EN.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a>\/\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102955\/Serbia_2020-EFPIA-Report_RS.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Serbian<\/strong><\/a><\/li>\n<li>2021 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102957\/Serbia_2021-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2022 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12111825\/Serbia_2022-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>Methodological note: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12111827\/Serbia_2022-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Slovakia<\/strong><\/p>\n<ul>\n<li>2022 EFPIA report in euro: <strong><a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/09\/13103307\/1.-EFPIA-DC_report_SVK-2022.pdf\" target=\"_blank\" rel=\"noopener\">Slovak<\/a><\/strong><\/li>\n<li>Methodological note:\u00a0<strong><a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/09\/13103312\/Metodika-zverejnovania-podla-EFPIA-DC-2022_IPSEN_SLOVAKIA.pdf\" target=\"_blank\" rel=\"noopener\">Slovak<\/a><\/strong><\/li>\n<li>Patient Support Program report for 2022 in euro: <strong><a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/09\/13103309\/2.-SK-POs-list-2022.pdf\" target=\"_blank\" rel=\"noopener\">English<\/a><\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Slovenia<\/strong><\/p>\n<ul>\n<li>No transfer of value in 2018, 2019, 2020<\/li>\n<li>2021 EFPIA report: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103004\/Slovenia_2022-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2022 EFPIA report: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12112218\/Slovenia_2022-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12112220\/Slovenia_2023-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsen.com\/spain\/ipsen-espana\/\" target=\"_blank\" rel=\"noopener\"><strong>Spain<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsennordic.com\/commitments\/transparency-in-relations-and-interests\/\" target=\"_blank\" rel=\"noopener\"><strong>Swede<\/strong><strong>n<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/ipsen-pharma.de\/verpflichtungen\/transparenz-und-vertrauen\/schweiz\/\" target=\"_blank\" rel=\"noopener\"><strong>Switzerland<\/strong><\/a><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong><a href=\"https:\/\/transparantieregister.nl\/home\" target=\"_blank\" rel=\"noopener\">The Netherlands<\/a><\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Ukraine<\/strong><\/p>\n<ul>\n<li>2018 EFPIA report in hryvnia:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103007\/Ukraine_2018-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ukrainian<\/strong><\/a><\/li>\n<li>2019 EFPIA report in hryvnia:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103008\/Ukraine_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ukrainian<\/strong><\/a><\/li>\n<li>2020 EFPIA report in euro:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103010\/Ukraine_2020-EFPIA-report_EN.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a>\/\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103011\/Ukraine_2020-EFPIA-report_UA.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ukrainian<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103013\/Ukraine_2021-Methodological-note_EN.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a>\/\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103015\/Ukraine_2021-Methodological-note_UA.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ukrainian<\/strong><\/a><\/li>\n<\/ul>\n<p><strong>United Kingdom\u00a0<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/www.abpi.org.uk\/our-ethics\/disclosure-uk\/\" target=\"_blank\" rel=\"noopener\"><strong>ABPI platform<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"expHeading5\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading10104231175\" aria-expanded=\"false\" aria-controls=\"expHeading10104231175\">\n                                                Support to patients and patient organizations                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading10104231175\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading5\" data-bs-parent=\"#accordionExample1010423117\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen actively collaborates with patient organizations to better understand and support patients\u2019 needs. Emphasizing transparency, we publicly disclose financial and non-financial support provided to these organizations in adherence to the EFPIA Code.<\/p>\n<p>&nbsp;<\/p>\n<p>Based on our dedication to transparency and under the EFPIA Patient Organizations Code, we make a list of patient organizations to which we provide financial support (grants, sponsorships, donations, etc. etc..) or significant non-financial support publicly available for viewing.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li>Year 2022: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/30191555\/2022_PO-disclosure-_EFPIA-report_30062023_final.pdf\" target=\"_blank\" rel=\"noopener\">European Countries<\/a><\/li>\n<li>Year 2021: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15085948\/2022-Ipsen_POs_Transparency_Year-2021_3006_EFPIA-1.pdf\" target=\"_blank\" rel=\"noopener\">European Countries<\/a><\/li>\n<li>Year 2020:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15085944\/2021-Ipsen_POs_Transparency_Year-2020_1712_all-countries-except-EU.pdf\" target=\"_blank\" rel=\"noopener\">All countries except EU<\/a>\u00a0\/\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15085941\/2021-Ipsen_POs_Transparency_Year-2020_1008_EFPIA.pdf\" target=\"_blank\" rel=\"noopener\">European Countries<\/a><\/li>\n<li>Year 2019:\u00a0<a href=\"https:\/\/www.ipsen.com\/wp-admin\/upload.php?item=23562\" target=\"_blank\" rel=\"noopener\">All countries except EU<\/a>\u00a0\/\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15085936\/2020-Ipsen_POs_Transparency_Year-2019_1007_EFPIA.pdf\" target=\"_blank\" rel=\"noopener\">European Countries<\/a><\/li>\n<li>Year 2018: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15085933\/2019-Ipsen_POs_Transparency-PC_Year-2018_final_0807.pdf\" target=\"_blank\" rel=\"noopener\">All countries<\/a><\/li>\n<li>Year 2017: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15085930\/2018-Ipsen_POs_Transparency_June2017_FIN.pdf\" target=\"_blank\" rel=\"noopener\">All countries<\/a><\/li>\n<\/ul>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"expHeading6\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading10104231176\" aria-expanded=\"false\" aria-controls=\"expHeading10104231176\">\n                                                Grants and donations                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading10104231176\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading6\" data-bs-parent=\"#accordionExample1010423117\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Motivated by our strategic commitment to society as a whole, we seek out opportunities to make an impact. In 2022, in response to the war in Ukraine, Ipsen donated \u20ac1.5 million to two organizations helping those impacted: disaster-relief organization Tulipe and the International Red Cross in France.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"expHeading7\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading10104231177\" aria-expanded=\"false\" aria-controls=\"expHeading10104231177\">\n                                                Clinical study transparency                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading10104231177\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading7\" data-bs-parent=\"#accordionExample1010423117\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen is committed to transparency in clinical studies, providing readily accessible information on clinical trials to patients, healthcare professionals and researchers. We publicly disclose protocol summaries and trial results, adhering to global industry standards, and share anonymized clinical study data with qualified researchers through the data-sharing platform, Vivli.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>Protocol Summary Disclosure<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Protocol summaries of Ipsen sponsored clinical trials are made publicly available on the US Clinical Trials Registry (<a href=\"http:\/\/www.clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener\">ClinicalTrials.gov<\/a>) and on the EU Clinical Trials Register (<a href=\"http:\/\/www.clinicaltrialsregister.eu\/\" target=\"_blank\" rel=\"noopener\">www.clinicaltrialsregister.eu<\/a>) at initiation of the clinical trial.<\/p>\n<p>For Post-Authorization Safety Studies (PASS) and Post-Authorization Efficacy Studies (PAES) that are outside the scope of Directive 2001\/20\/EC, protocol summaries are posted in the EU electronic\u00a0<a href=\"http:\/\/www.encepp.eu\/encepp\/studiesDatabase.jsp\" target=\"_blank\" rel=\"noopener\">Register of Post-Authorization Studies<\/a>\u00a0(EU PAS Register) at initiation of the clinical trial.<\/p>\n<p>We also provide clinical trial information to other national clinical trial registries or databases according to local requirements\/legislation.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>Disclosure of Clinical Trial Results<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>ClinicalTrials.gov<br \/>\n<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>The results of Ipsen clinical trials are publicly posted to the results database after completion or termination of a clinical trial. Clinical trial results are usually available within 12 months of the trial completion or termination date. Results of clinical trials that are subject to FDAAA 801 legislation have been posted on\u00a0<a href=\"http:\/\/www.clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener\">ClinicalTrials.gov<\/a>\u00a0since June 2009. Since January 2014, Ipsen posts results from all Ipsen sponsored interventional clinical trials in patients.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>EU Clinical Trials Register<br \/>\n<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>From 21st July 2015, results summaries of Ipsen sponsored interventional clinical trials in patients conducted in the EU\/EEA that completed from 21st July 2013 are available on the\u00a0<a href=\"http:\/\/www.encepp.eu\/encepp\/studiesDatabase.jsp\" target=\"_blank\" rel=\"noopener\">EU Clinical Trials Register<\/a>. Results of interventional clinical trials are published one year after completion. From 21st July 2016, it is expected that all trials that started since May 2004 and completed before 21st July 2013 will also be made available here.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>Sharing Clinical Trial Data with Qualified Researchers<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Ipsen is committed to sharing anonymized clinical study data from completed Phase II to IV studies for products and indications approved in the United States and\/or in the European Union, with a first patient included as of 1 Jan 2005 onwards. Ipsen is pleased to be member of the data sharing platform\u00a0<a href=\"https:\/\/eur01.safelinks.protection.outlook.com\/?url=http%3A%2F%2Fwww.vivli.org%2F&amp;data=05%7C01%7Ckonstantinos.kampanos%40ipsen.com%7Cb85ccc05b7f540a4543308da802b1a0a%7C9e776b6aa6cc4fafa054a502153beb01%7C0%7C0%7C637963219856591242%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=z3eNYKBeJEHLVeV62X4c9jsDTWwoCiI6XfOQTUQOkBQ%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\">www.vivli.org<\/a>.\u00a0Available studies are listed on this platform. Ipsen will regularly update this list to add eligible studies.\u00a0Any requests should be submitted to\u00a0<a href=\"https:\/\/eur01.safelinks.protection.outlook.com\/?url=http%3A%2F%2Fwww.vivli.org%2F&amp;data=05%7C01%7Ckonstantinos.kampanos%40ipsen.com%7Cb85ccc05b7f540a4543308da802b1a0a%7C9e776b6aa6cc4fafa054a502153beb01%7C0%7C0%7C637963219856591242%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=z3eNYKBeJEHLVeV62X4c9jsDTWwoCiI6XfOQTUQOkBQ%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\">www.vivli.org<\/a>\u00a0for assessment by an independent scientific review board.\u00a0Anonymized data will be provided to qualified researchers through Vivli\u2019s platform upon approval of the research proposal and signature of a Data Use\/Sharing Agreement.<\/p>\n<p>&nbsp;<\/p>\n<p>Additional details on Ipsen data sharing policy are available\u00a0<a href=\"https:\/\/vivli.org\/members\/ourmembers\/\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"expHeading8\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading10104231178\" aria-expanded=\"false\" aria-controls=\"expHeading10104231178\">\n                                                Animal welfare                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading10104231178\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading8\" data-bs-parent=\"#accordionExample1010423117\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen does not have internal animal research facilities. Although Ipsen outsources its animal testing, it has put in place an Animal Welfare governance body ensuring the appropriate treatment of animals. We are signatories of Gircor\u2019s \u201cFrench Charter for Transparency on the Use of Animals for Scientific and Regulatory Purposes,\u201d and actively pursue the 3Rs: reduction, refinement and replacement of animal experimentation.<\/p>\n<p>&nbsp;<\/p>\n<p>Patients and society are at the core of Ipsen\u2019s mission to improve lives and health outcomes. Biological and medical research are critical to continuously increasing scientific knowledge and improving human health. While animal studies continue to play an important role in the medical research process and in the development of treatments improving the quality of life of millions of people, it is our priority to meet the highest possible standards of animal welfare. That\u2019s why we are among the signatories of the \u201cFrench Charter for Transparency on the Use of Animals for Scientific and Regulatory Purposes\u201d developed by the GIRCOR.<\/p>\n<ul>\n<li><a class=\"cta cta--primary has-shadow\" href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15131119\/French-Transparency-Charter-Animals-for-Science.pdf\" target=\"_blank\" rel=\"noopener\"><span class=\"cta__label\">Download the Charter<\/span><\/a><\/li>\n<li><a class=\"cta cta--primary has-shadow\" href=\"https:\/\/www.gircor.fr\/telechargements\/charte-de-transparence-rapport-2021-uk\/\" target=\"_blank\" rel=\"noopener\"><span class=\"cta__label\">Download the annual report 2021<\/span><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Ipsen\u2019s Cell-Based Assay is now fully implemented for its DYSPORT<sup>\u00ae<\/sup>\u00a0products supplied to the U.S., Canada, E.U. and Switzerland.<\/p>\n<ul>\n<li><a class=\"cta cta--primary has-shadow\" href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15131117\/00-IAW-ONLINE-POSITION-STATEMENT_Ipsens-CBA-implementation-EN-2020-02-25.pdf\" target=\"_blank\" rel=\"noopener\"><span class=\"cta__label\">Download Ipsen\u2019s position statement on the Cell-Based Assay<\/span><\/a><\/li>\n<\/ul>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p  role=\"heading\" aria-level=\"3\" class=\"accordion-header accor-head-para\" id=\"expHeading9\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading10104231179\" aria-expanded=\"false\" aria-controls=\"expHeading10104231179\">\n                                                Early access policy                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading10104231179\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading9\" data-bs-parent=\"#accordionExample1010423117\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><h5>Ipsen\u2019s vision is to be a leading global biopharmaceutical company focused on innovation and Specialty Care and our mission is to improve patients\u2019 lives through innovative new medicines<\/h5>\n<p>&nbsp;<\/p>\n<p>Ipsen commits to enable Early Access to patients to Ipsen Products which are not yet approved by local Health Authorities, hence not yet available for prescription, when the Ipsen Product is considered as eligible for Early Access.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>What is \u201cEarly Access\u201d:<\/strong><\/p>\n<p>Ipsen defines \u201cEarly Access\u201d<sup>1<\/sup>\u00a0as access to:<\/p>\n<ol>\n<li>Unapproved medicine for the requested indication in the country where the request comes from<\/li>\n<li>For life-threatening or serious medical conditions<\/li>\n<li>Where there is no satisfactory alternative therapy available for the given medical condition<\/li>\n<li>Where there is no alternative option for the patient to participate in an ongoing clinical trial in the given indication<\/li>\n<li>Where the medicine has reasonable medical evidence of the positive balance of benefits\/risks in the given indication and the medicinal product has started the regulatory process of approval in the US and\/or the EU<\/li>\n<\/ol>\n<p>Early Access can only take place if it is allowed within the local laws, rules and regulations or specifically approved in writing by local authorities.<\/p>\n<p>&nbsp;<\/p>\n<p>The physician and the patient should discuss the expected benefits, known and potential unknown risks before seeking Early Access to a medicinal product.<\/p>\n<p>&nbsp;<\/p>\n<p>In some cases, Ipsen may set up a program designed to provide Early Access to several patients in defined countries.<\/p>\n<p>&nbsp;<\/p>\n<p>The list of Ipsen\u2019s Early Access Programs in the United States is available on\u00a0<a href=\"http:\/\/www.clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener\">www.clinicaltrials.gov<\/a>.<\/p>\n<h3><\/h3>\n<h5>Request for Early Access to an Ipsen Product:<\/h5>\n<p>&nbsp;<\/p>\n<p><strong>Who can request Early Access?<\/strong><\/p>\n<p>Only qualified Physicians can make requests for Early Access to an Ipsen Product once they have exhausted all other appropriate and available options to treat the medical condition of their patient, including enrollment in a clinical trial.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>How can the Physician contact Ipsen and make a request?<\/strong><\/p>\n<p>Physicians can contact Ipsen and send a request for Early Access to:\u00a0<a href=\"mailto:GlobalMedInfo@ipsen.com\">GlobalMedInfo@ipsen.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>What will happen to the request?<\/strong><\/p>\n<p>When the request is received by Ipsen, Ipsen will send an acknowledgement of receipt of the request within 48 business hours. The request will be assessed by Ipsen medical affairs fairly, as promptly as possible and after a thorough discussion with the Physician as necessary.<\/p>\n<p>&nbsp;<\/p>\n<p>The decision will be based on at least the following criteria:<\/p>\n<ol>\n<li>The conditions for Early Access are met<\/li>\n<li>Patient\u2019s individual medical conditions<\/li>\n<li>Ipsen product availability<\/li>\n<li>Regulatory and health system environment where the request has come from (e.g. to make sure a Pharmacovigilance structure is in place)<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p><strong>What will happen if the request is approved?\u00a0<\/strong><\/p>\n<p>If the request for Early Access is approved by Ipsen, the Physician must collect and complete all necessary documents to comply with appropriate rules and regulations \u2013 as quickly as possible. Once collected, Ipsen will send the Physician the requested Ipsen Product for Early Access to treat their patient.<\/p>\n<p>&nbsp;<\/p>\n<p>The physician must commit to the regulatory obligations including reporting of adverse events during the entirety of the Early Access.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>What will happen if the request is not approved?<\/strong><\/p>\n<p>Ipsen is committed to Early Access but the company cannot guarantee approval and regrets that there are occasions where it is not appropriate for the company to provide Early Access to its medicine or where the request does not fall within the definition of Early Access. In these circumstances we commit to provide a timely response and clear rationale for the decision.<\/p>\n<p>&nbsp;<\/p>\n<p><sub><sup>1<\/sup><em>Other terms commonly used: Compassionate Use, Early Access, Expanded Access Program, Managed Access Program, Patient Access Program, Special Access Program, Scheme Access Program, Temporary Use Authorization and Pre-approval access.<\/em><\/sub><\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                                                <\/div>\n                <\/div> \n            <\/div>\n        <\/div>\n    <\/section>\n    <!--Accordion Cards End Here-->\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":77,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-85","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ipsen responsibility: Governance<\/title>\n<meta name=\"description\" content=\"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen responsibility: Governance\" \/>\n<meta property=\"og:description\" content=\"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/\" \/>\n<meta property=\"og:site_name\" content=\"Australia\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-15T05:03:53+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/\",\"url\":\"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/\",\"name\":\"Ipsen responsibility: Governance\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/aus\/#website\"},\"datePublished\":\"2023-11-07T10:19:47+00:00\",\"dateModified\":\"2024-02-15T05:03:53+00:00\",\"description\":\"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/aus\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Responsibility\",\"item\":\"https:\/\/www.ipsen.com\/aus\/responsibility\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Governance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/aus\/#website\",\"url\":\"https:\/\/www.ipsen.com\/aus\/\",\"name\":\"Australia\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/aus\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/aus\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/aus\/#organization\",\"name\":\"Australia\",\"url\":\"https:\/\/www.ipsen.com\/aus\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/aus\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"Australia\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/aus\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen responsibility: Governance","description":"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/","og_locale":"en_US","og_type":"article","og_title":"Ipsen responsibility: Governance","og_description":"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.","og_url":"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/","og_site_name":"Australia","article_modified_time":"2024-02-15T05:03:53+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/","url":"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/","name":"Ipsen responsibility: Governance","isPartOf":{"@id":"https:\/\/www.ipsen.com\/aus\/#website"},"datePublished":"2023-11-07T10:19:47+00:00","dateModified":"2024-02-15T05:03:53+00:00","description":"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/aus\/responsibility\/governance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/aus\/"},{"@type":"ListItem","position":2,"name":"Responsibility","item":"https:\/\/www.ipsen.com\/aus\/responsibility\/"},{"@type":"ListItem","position":3,"name":"Governance"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/aus\/#website","url":"https:\/\/www.ipsen.com\/aus\/","name":"Australia","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/aus\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/aus\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/aus\/#organization","name":"Australia","url":"https:\/\/www.ipsen.com\/aus\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/aus\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/12\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/aus\/wp-content\/uploads\/sites\/5\/2023\/12\/Latest_Ipsen-logo_168x48.svg","caption":"Australia"},"image":{"@id":"https:\/\/www.ipsen.com\/aus\/#\/schema\/logo\/image\/"}}]}},"parsely":{"version":"1.1.0","canonical_url":"https:\/\/ipsen.com\/aus\/responsibility\/governance\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"WebPage","headline":"Governance","url":"http:\/\/www.ipsen.com\/aus\/responsibility\/governance\/","mainEntityOfPage":{"@type":"WebPage","@id":"http:\/\/www.ipsen.com\/aus\/responsibility\/governance\/"},"thumbnailUrl":"","image":{"@type":"ImageObject","url":""},"articleSection":"Uncategorized","author":[{"@type":"Person","name":"Dipika"}],"creator":["Dipika"],"publisher":{"@type":"Organization","name":"Australia","logo":""},"keywords":[],"dateCreated":"2023-11-07T10:19:47Z","datePublished":"2023-11-07T10:19:47Z","dateModified":"2024-02-15T05:03:53Z"},"rendered":"<script type=\"application\/ld+json\" class=\"wp-parsely-metadata\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"WebPage\",\"headline\":\"Governance\",\"url\":\"http:\\\/\\\/www.ipsen.com\\\/aus\\\/responsibility\\\/governance\\\/\",\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/www.ipsen.com\\\/aus\\\/responsibility\\\/governance\\\/\"},\"thumbnailUrl\":\"\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"\"},\"articleSection\":\"Uncategorized\",\"author\":[{\"@type\":\"Person\",\"name\":\"Dipika\"}],\"creator\":[\"Dipika\"],\"publisher\":{\"@type\":\"Organization\",\"name\":\"Australia\",\"logo\":\"\"},\"keywords\":[],\"dateCreated\":\"2023-11-07T10:19:47Z\",\"datePublished\":\"2023-11-07T10:19:47Z\",\"dateModified\":\"2024-02-15T05:03:53Z\"}<\/script>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/ipsen.com\/p.js"},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/aus\/wp-json\/wp\/v2\/pages\/85","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/aus\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ipsen.com\/aus\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/aus\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/aus\/wp-json\/wp\/v2\/comments?post=85"}],"version-history":[{"count":38,"href":"https:\/\/www.ipsen.com\/aus\/wp-json\/wp\/v2\/pages\/85\/revisions"}],"predecessor-version":[{"id":1054,"href":"https:\/\/www.ipsen.com\/aus\/wp-json\/wp\/v2\/pages\/85\/revisions\/1054"}],"up":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/aus\/wp-json\/wp\/v2\/pages\/77"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/aus\/wp-json\/wp\/v2\/media?parent=85"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}